Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Healthtrust
Baxter
UBS
McKinsey
Harvard Business School
Deloitte
Daiichi Sankyo
Cipla

Generated: August 17, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eprosartan mesylate; hydrochlorothiazide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abbvie
TEVETEN HCT
eprosartan mesylate; hydrochlorothiazide
TABLET;ORAL021268NDAPhysicians Total Care, Inc.54868-5281-130 TABLET in 1 BOTTLE (54868-5281-1)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Queensland Health
Johnson and Johnson
UBS
Moodys
US Department of Justice
Mallinckrodt
Citi
Teva

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot